Select license type

Please Select Linenece Type

Key Benefits

  • Consult directly with our domain leaders and get expert advice regarding the upcoming market.
  • Get the latest market insights and forecasts backed up by powerful research and statistical analysis
  • Customize the report as per your requirements and area of focus to avail great benefits for your business.

our clients
tiltle-brk

client-logo
client-logo2
client-logo3
client-logo4
client-logo
client-logo
client-logo
client-logo

"The quality of representation was outstanding. I never thought that understanding a complex market can be that much easy"

Adam Smith, Associate Director, Bain Capital

"More than just selling a report, the team was more focused towards the understanding of my requirements. Regular updation was the best part."

Koh Vivian, Product Development Manager, Swiss Bio Pharma

"Hats off to expert analysis, the team was very supporting and thanks for not charging me on additional data."

Erin Green, Director, Green Energy Consulting

" I really want to thank Goldstein Research for their efforts to make my project successful. F2F discussion with the market experts was excellent. Keep up the good work guyz "

Jorge Foyo, , Analyst, BCG
Market Research Report

Aptamers Market- Industry Trends, Share, Demand, Y-o-Y Growth Rate, Scope, Forecast Period 2016-2024

Published On : 2018-02-06 Report Page : 310 Category: Healthcare

Global Aptamers Market

Market Overview

Aptamer sometimes referred to as “synthetic antibody” is the stable DNA, RNA, or peptide that binds with high affinity and specificity to targets such as small organics, peptides, proteins, cells, and tissues, unlike antibodies, some aptamers exhibit stereoselectivity. Aptamers are emerging as a key player in numerous applications such as drug discovery and therapeutics development, in addition to biodefense, food science, and more.

Goldstein Research analyst forecast the Aptamers Market size is set to reach USD 5.1 billion by 2024, at a CAGR of 67.2% over the forecast years.

 

Covered In This Global Aptamers Market Report                         

The report covers the present ground scenario and the future growth prospects of the Aptamers Market for 2016-2024 along with the adoption rate of aptameters in various applications and the ongoing research in aptamers. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe.

Global Aptamers Market Segmentation

By Type

  • Nucleic Acid Aptamers
    • DNA-Based Aptamers
    • RNA-Based Aptamers
    • XNA-Based Aptamers
  • Peptide Aptamers

By Technology

  • Systematic Evolution Of Ligands By Exponential Enrichment Technology (SELEX)
  • Others

By Application

  • Diagnostic reagents
  • Biosensors
  • Forensics
  • Biodefense
  • Cancer
  • Therapeutics and drug delivery

By End User

  • Bio-Pharmaceutical companies
  • Pharmaceutical Companies
  • Academic and Research centers
  • Contract Research Organization

Based on Geography

  • North America (U.S. & Canada) Aptamers Market
  • Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Aptamers Market
  • Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Aptamers Market
  • Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Aptamers Market
  • Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Aptamers Market

On the basis of end user, the academic and government research institutes held the largest share (37.8%) of the aptamers market in 2016. The biotechnology and pharmaceutical companies are expected to be the fastest-growing end-user segment with the CAGR of 70% between 2017 and 2024 due to high demand of aptamer molecules across a diverse range of medical applications.     

Aptamers Market Outlook 2016-2024, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Aptamers Market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global Aptamers Market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Our global Aptamers Market report comprises of the following companies as the key players: Somalogic, Inc., NOXXAN Pharma AG, Aptamer Science, Inc., Aptagen, Inc, AM Biotechnologies, LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies, Inc., NeoVentures Biotechnology, Inc., TriLink BioTechnologies, Inc., and Vivonics, Inc.

According to our global market study on the basis of extensive primary and secondary research:  “One trend is that hundreds of aptamer-related experiments are now underway and/or have been recently reported in literature, covering a wide variety of fields like probes designed to detect trace amounts of mercury in water, rapid detection system for E.coli, visualization of latent fingerprints in forensics and chemotherapy drug delivery systems for targeting pancreatic cancer cells.”

According to the report, major driving factor for Aptamers Market is its diverse application in diagnostics for instance, biomedical diagnostics for detection of disease biomarkers. Diagnostic-based aptamer kits have been developed for detecting mycotoxins and aflatoxins. One very interesting technology developed by Aptagen is the aptamer-beacon (i.e., Apta-beacon) technology which can be used for rapid biomarker detection.   

Further, the report states that the limitation of aptamers includes the rapid clearance rate from circulation due to their small size and degradation by nucleases for the unmodified aptamers. However, these limitations can be easily resolved by chemically modifying the aptamers.

Based on geography, North America lead the Aptamers Market with the market share of 40% in 2016 due to growing incidence of life-threatening diseases such as cancer which has directed many companies to introduce new & effective detection assays based on aptamer therapy. Europe region is expected to witness strong growth at a CAGR of 68% owing to presence of key players in the market while Asia Pacific has the potential to register positive growth owing to increased opportunities in diagnostics and development of pharmaceuticals which are remain untapped in the aptamers market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Aptamers Market report

  • What is the total market size of global aptamers market by 2024 and what would be the expected growth rate of the market?
  • What is the revenue of Aptamers in 2015-16 and what would be the expected demand over the forecast period?
  • What are the key market trends?
  • What are the factors which are driving this market?
  • What are the major barriers to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities for the existing and entry level players?
  • What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.


Aptamer Market- Table of Content

 

1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Data Analyzing & Market Size Estimation 
1.4. Research Design
1.5. Bottom-Up & Top-Down Approach
 
2. Market Environment
2.1. Global Economic Overview
2.2. Macroeconomic Outlook
2.3. Global Healthcare Therapeutics Industry Outlook
2.4. Global Drug Discovery Market Outlook
2.5. Global Biomedical Diagnostics Market Outlook
2.6. Technology Outlook
2.7. Investments Outlook
2.8. Regulatory & Environmental Considerations
2.9. Competitive Strategies
2.10. Acquisitions & Divestitures
2.11. Supply & Demand Outlook
2.12. Marketing & Distribution
 
3. Executive Summary
3.1. Market Size (USD Million)
3.2. Forecast Analysis (2017-2025)
3.3. Market Share & CAGR (%)
3.4. Regional Share Distribution (%)
 
4. Market Dynamics
4.1. Growth Drivers
4.2. Market Restraints
4.3. Risk Analysis (Demand Risk & Supply Risk Analysis)
4.4. Recent Trends & Developments
4.5. Opportunities for Market Players
 
5. Global Aptamer Market Segmentation
 
5.1. Aptamer Market ByType(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.1.1. Market Share(%) of Aptamer Market by Type
5.1.2. Nucleic Acid Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.1.2.1. DNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.1.2.2. RNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.1.2.3. XNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.1.3. Peptide Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.1.4. Market Attractiveness of Aptamer Market byType
5.1.5. BPS Analysis of Aptamer Market by Type
 
5.2. Aptamer Market By Technology(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.2.1. Market Share(%) of Aptamer Market by Technology
5.2.2. Systematic Evolution Of Ligands By Exponential Enrichment Technology (SELEX) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.2.3. Others (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.2.4. Market Attractiveness of Aptamer Market by Technology
5.2.5. BPS Analysis of Aptamer Market by Technology
 
5.3. Aptamer Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.3.1. Market Share(%) of Aptamer Market by Application
5.3.2. Diagnostic reagents (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.3.3. Biosensors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.3.4. Forensics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.3.5. Biodefense (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.3.6. Cancer (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.3.7. Therapeutics and drug delivery (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.3.8. Market Attractiveness of Aptamer Market by Application
5.3.9. BPS Analysis of Aptamer Market by Application
 
5.4. Aptamer Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.4.1. Market Share(%) of Aptamer Market by End User
5.4.2. Bio-Pharmaceutical companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.4.3. Pharmaceutical Companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.4.4. Academic and Research centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.4.5. Contract Research Organization  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.4.6. Market Attractiveness of Aptamer Market by End User
5.4.7. BPS Analysis of Aptamer Market by End User
 
5.5. Aptamer Market By Region (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
 
5.5.1. North America Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
5.5.1.1. North America Aptamer Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
5.5.1.1.1. U.S. Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.1.2. Canada Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.1.3. Market Attractiveness of Aptamer Market by Country
5.5.1.1.4. BPS Analysis of Aptamer Market by Country
 
5.5.1.2. North America Aptamer Market By Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.2.1. Market Share(%) of Aptamer Market by Type
5.5.1.2.2. Nucleic Acid Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.2.2.1. DNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.2.2.2. RNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.2.2.3. XNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.2.3. Peptide Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.2.4. Market Attractiveness of Aptamer Market by Type
5.5.1.2.5. BPS Analysis of Aptamer Market by Type
 
5.5.1.3. North America Aptamer Market By Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.3.1. Market Share(%) of Aptamer Market by Technology
5.5.1.3.2. Systematic Evolution Of Ligands By Exponential Enrichment Technology (SELEX) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.3.3. Others (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.3.4. Market Attractiveness of Aptamer Market by Technology
5.5.1.3.5. BPS Analysis of Aptamer Market by Technology
 
5.5.1.4. North America Aptamer Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.4.1. Market Share(%) of Aptamer Market by Application
5.5.1.4.2. Diagnostic reagents (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.4.3. Biosensors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.4.4. Forensics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.4.5. Biodefense (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.4.6. Cancer (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.4.7. Therapeutics and drug delivery (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.4.8. Market Attractiveness of Aptamer Market by Application
5.5.1.4.9. BPS Analysis of Aptamer Market by Application
 
5.5.1.5. North America Aptamer Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.5.1. Market Share(%) of Aptamer Market by End User
5.5.1.5.2. Bio-Pharmaceutical companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.5.3. Pharmaceutical Companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.5.4. Academic and Research centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.5.5. Contract Research Organization  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.1.5.6. Market Attractiveness of Aptamer Market by End User
5.5.1.5.7. BPS Analysis of Aptamer Market by End User
 
5.5.2. Europe Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
5.5.2.1. Europe Aptamer Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
5.5.2.1.1. UK Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.1.2. France Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.1.3. Italy Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.1.4. Germany Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.1.5. Spain Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.1.6. Hungary Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.1.7. Sweden Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.1.8. Russia Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.1.9. Poland Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.1.10. Rest of Europe Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.1.11. Market Attractiveness of Aptamer Market by Country
5.5.2.1.12. BPS Analysis of Aptamer Market by Country
 
5.5.2.2. Europe Aptamer Market By Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.2.1. Market Share(%) of Aptamer Market by Type
5.5.2.2.2. Nucleic Acid Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.2.2.1. DNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.2.2.2. RNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.2.2.3. XNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.2.3. Peptide Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.2.4. Market Attractiveness of Aptamer Market by Type
5.5.2.2.5. BPS Analysis of Aptamer Market by Type
 
5.5.2.3. Europe Aptamer Market By Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.3.1. Market Share(%) of Aptamer Market by Technology
5.5.2.3.2. Systematic Evolution Of Ligands By Exponential Enrichment Technology (SELEX) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.3.3. Others (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.3.4. Market Attractiveness of Aptamer Market by Technology
5.5.2.3.5. BPS Analysis of Aptamer Market by Technology
 
5.5.2.4. Europe Aptamer Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.4.1. Market Share(%) of Aptamer Market by Application
5.5.2.4.2. Diagnostic reagents (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.4.3. Biosensors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.4.4. Forensics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.4.5. Biodefense (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.4.6. Cancer (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.4.7. Therapeutics and drug delivery (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.4.8. Market Attractiveness of Aptamer Market by Application
5.5.2.4.9. BPS Analysis of Aptamer Market by Application
 
5.5.2.5. Europe Aptamer Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.5.1. Market Share(%) of Aptamer Market by End User
5.5.2.5.2. Bio-Pharmaceutical companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.5.3. Pharmaceutical Companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.5.4. Academic and Research centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.5.5. Contract Research Organization  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.2.5.6. Market Attractiveness of Aptamer Market by End User
5.5.2.5.7. BPS Analysis of Aptamer Market by End User
 
5.5.3. Middle East & Africa Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
5.5.3.1. Middle East & Africa Aptamer Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
5.5.3.1.1. Gulf Cooperation Council Countries (GCC) Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.1.2. South Africa Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.1.3. North Africa Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.1.4. Rest of Middle East and Africa Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.1.5. Market Attractiveness of Aptamer Market by Country 
5.5.3.1.6. BPS Analysis of Aptamer Market by Country
 
5.5.3.2. Middle East & Africa Aptamer Market By Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.2.1. Market Share(%) of Aptamer Market by Type
5.5.3.2.2. Nucleic Acid Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.2.2.1. DNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.2.2.2. RNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.2.2.3. XNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.2.3. Peptide Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.2.4. Market Attractiveness of Aptamer Market by Type
5.5.3.2.5. BPS Analysis of Aptamer Market by Type
 
5.5.3.3. Middle East & Africa Aptamer Market By Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.3.1. Market Share(%) of Aptamer Market by Technology
5.5.3.3.2. Systematic Evolution Of Ligands By Exponential Enrichment Technology (SELEX) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.3.3. Others (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.3.4. Market Attractiveness of Aptamer Market by Technology
5.5.3.3.5. BPS Analysis of Aptamer Market by Technology
 
5.5.3.4. Middle East & Africa Aptamer Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.4.1. Market Share(%) of Aptamer Market by Application
5.5.3.4.2. Diagnostic reagents (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.4.3. Biosensors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.4.4. Forensics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.4.5. Biodefense (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.4.6. Cancer (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.4.7. Therapeutics and drug delivery (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.4.8. Market Attractiveness of Aptamer Market by Application
5.5.3.4.9. BPS Analysis of Aptamer Market by Application
 
5.5.3.5. Middle East & Africa Aptamer Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.5.1. Market Share(%) of Aptamer Market by End User
5.5.3.5.2. Bio-Pharmaceutical companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.5.3. Pharmaceutical Companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.5.4. Academic and Research centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.5.5. Contract Research Organization  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.3.5.6. Market Attractiveness of Aptamer Market by End User
5.5.3.5.7. BPS Analysis of Aptamer Market by End User
 
5.5.4. Latin America Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
5.5.4.1. Latin America Aptamer By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
5.5.4.1.1. Brazil Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.1.2. Mexico Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.1.3. Rest of Latin America Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.1.4. Market Attractiveness of Aptamer Market by Country 
5.5.4.1.5. BPS Analysis of Aptamer Market by Country
 
5.5.4.2. Latin America Aptamer Market By Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.2.1. Market Share(%) of Aptamer Market by Type
5.5.4.2.2. Nucleic Acid Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.2.2.1. DNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.2.2.2. RNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.2.2.3. XNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.2.3. Peptide Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.2.4. Market Attractiveness of Aptamer Market by Type
5.5.4.2.5. BPS Analysis of Aptamer Market by Type
 
5.5.4.3. Latin America Aptamer Market By Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.3.1. Market Share(%) of Aptamer Market by Technology
5.5.4.3.2. Systematic Evolution Of Ligands By Exponential Enrichment Technology (SELEX) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.3.3. Others (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.3.4. Market Attractiveness of Aptamer Market by Technology
5.5.4.3.5. BPS Analysis of Aptamer Market by Technology
 
5.5.4.4. Latin America Aptamer Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.4.1. Market Share(%) of Aptamer Market by Application
5.5.4.4.2. Diagnostic reagents (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.4.3. Biosensors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.4.4. Forensics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.4.5. Biodefense (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.4.6. Cancer (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.4.7. Therapeutics and drug delivery (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.4.8. Market Attractiveness of Aptamer Market by Application
5.5.4.4.9. BPS Analysis of Aptamer Market by Application
 
5.5.4.5. Latin America Aptamer Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.5.1. Market Share(%) of Aptamer Market by End User
5.5.4.5.2. Bio-Pharmaceutical companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.5.3. Pharmaceutical Companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.5.4. Academic and Research centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.5.5. Contract Research Organization  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.4.5.6. Market Attractiveness of Aptamer Market by End User
5.5.4.5.7. BPS Analysis of Aptamer Market by End User
 
5.5.5. Asia Pacific (APAC) Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
5.5.5.1. Asia Pacific Aptamer Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
5.5.5.1.1. China Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.1.2. Japan Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.1.3. India Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.1.4. Singapore Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.1.5. South Korea Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.1.6. Australia Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.1.7. New Zealand Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.1.8. Rest of APAC Aptamer Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.1.9. Market Attractiveness of Aptamer Market by Country 
5.5.5.1.10. BPS Analysis of Aptamer Market by Country
 
5.5.5.2. Asia Pacific Aptamer Market By Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.2.1. Market Share(%) of Aptamer Market by Type
5.5.5.2.2. Nucleic Acid Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.2.2.1. DNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.2.2.2. RNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.2.2.3. XNA-Based Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.2.3. Peptide Aptamers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.2.4. Market Attractiveness of Aptamer Market by Type
5.5.5.2.5. BPS Analysis of Aptamer Market by Type
 
5.5.5.3. Asia Pacific Aptamer Market By Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.3.1. Market Share(%) of Aptamer Market by Technology
5.5.5.3.2. Systematic Evolution Of Ligands By Exponential Enrichment Technology (SELEX) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.3.3. Others (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.3.4. Market Attractiveness of Aptamer Market by Technology
5.5.5.3.5. BPS Analysis of Aptamer Market by Technology
 
5.5.5.4. Asia Pacific Aptamer Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.4.1. Market Share(%) of Aptamer Market by Application
5.5.5.4.2. Diagnostic reagents (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.4.3. Biosensors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.4.4. Forensics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.4.5. Biodefense (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.4.6. Cancer (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.4.7. Therapeutics and drug delivery (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.4.8. Market Attractiveness of Aptamer Market by Application
5.5.5.4.9. BPS Analysis of Aptamer Market by Application
 
5.5.5.5. Asia Pacific Aptamer Market By End User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.5.1. Market Share(%) of Aptamer Market by End User
5.5.5.5.2. Bio-Pharmaceutical companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.5.3. Pharmaceutical Companies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.5.4. Academic and Research centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.5.5. Contract Research Organization  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
5.5.5.5.6. Market Attractiveness of Aptamer Market by End User
5.5.5.5.7. BPS Analysis of Aptamer Market by End User
 
6. Competitive Outlook
6.1. Market Share of Major Players (2016)
6.2. Company Profiles
6.2.1. Aptamer Science, Inc.
6.2.1.1. Company Synopsis
6.2.1.2. Business Strategy
6.2.1.3. Product Portfolio
6.2.1.4. SWOT Analysis
6.2.2. Somalogic, Inc.
6.2.3. NOXXAN Pharma AG
6.2.4. Aptagen, Inc
6.2.5. AM Biotechnologies
6.2.6. Aptamer Solutions Ltd.
6.2.7. Aptus Biotech S.L.
6.2.8. Base Pair Biotechnologies, Inc.
6.2.9. NeoVentures Biotechnology, Inc.
6.2.10. TriLink BioTechnologies, Inc.
6.2.11. Vivonics, Inc.
 
7. Porter’s Five Force Model
8. Market Landscape: Competition and Beyond
9. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
10. Expert Analysis
11. Concluding Remarks

Aptamers Market- Industry Trends, Share, Demand, Y-o-Y Growth Rate, Scope, Forecast Period 2016-2024

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747